BASIL-1试验:男女CLTI血运重建的近期与远期结局比较
该研究基于BASIL-1随机试验的病例记录表,按符合方案集分析比较男性和女性因严重肢体缺血行膝下血运重建的结局。女性年龄更大、吸烟和糖尿病比例更低、接受最佳药物治疗更少,男性坏疽更多;两性ABPI、住院时间和30天并发症及死亡率相近,但女性3年无截肢生存、总生存和无主要不良肢体事件生存均显著更优。
要点
- 女性CLTI患者血运重建后远期无截肢生存、总生存及无MALE生存优于男性
- 两性短期结局(住院时间、30天并发症和死亡率)相似
- 制定CLTI早期血运重建策略时应将性别作为独立预后因素考虑
核心结论
- 在BASIL-1试验中,女性血运重建后短期结局与男性相似,但远期结局更好。
- 性别是CLTI血运重建后结局的独立危险因素,也是症状性PAD发生的独立危险因素。
研究设计与样本
- 研究数据来自BASIL-1试验病例记录表,该试验于1999至2004年随机纳入452例患者,比较膝下病变所致严重肢体缺血的旁路手术与血管成形术。
- 采用符合方案集分析,用Cox比例风险模型检验性别与无截肢生存、总生存和无主要不良肢体事件生存的关系。
主要发现
- 随机分组时女性年龄更大,吸烟、糖尿病和接受推荐最佳药物治疗的比例更低,男性坏疽比例更高。
- 男女ABPI、血运重建后住院时间及30天并发症和死亡率相似。
临床怎么用
- 在为CLTI制定早期循证治疗路径和血运重建策略时,应将性别纳入考虑。
- 女性患者短期结局与男性相近,但需关注其远期生存和无截肢结局的相对优势及相关混杂因素。
局限性
- 原文摘要未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reports from cohort studies comparing outcomes after revascularisation for chronic limb threatening ischaemia (CLTI) between men and women remain controversial. Anatomical and clinical disease severity is often heterogeneous, and treatment choice influenced by a variety of clinician and patient factors. The aim was to compare outcomes in men and women entered into the only randomised study comparing bypass and angioplasty for infra-inguinal disease causing severe limb ischaemia. METHODS: Data were obtained from BASIL-1 trial case record forms. Baseline demographics were compared, and Cox proportional hazard models were used to examine the relationship between sex and amputation free survival (AFS), overall survival (OS), and freedom from major adverse limb events (FF-MALE) using a per-protocol analysis. Data were analysed using a per-protocol analysis. RESULTS: A total of 452 patients were randomised into the BASIL-1 trial from 1999 to 2004. At randomisation, women were older and less likely to be smokers, to have diabetes, or to be on recommended best medical therapy. Men were more likely to present with gangrene. Ankle brachial pressure index (ABPI), post-revascularisation length of hospital stay, and 30 day morbidity and mortality were similar for men and women. At three years, female sex was associated with significantly better AFS (HR 0.65, 95% CI 0.47-0.89, p < .01), OS (HR 0.66 95% CI 0.46-0.95, p = .02) and FF-MALE (HR 0.74, 95% CI 0.57-0.96, p = .02). CONCLUSION: In the BASIL-1 trial, women had similar short term but better long term outcomes after revascularisation. Sex is an important consideration when developing early, evidence based treatment pathway and revascularisation strategies for CLTI, and is an independent risk factor for outcomes following revascularisation as well as development of symptomatic PAD.
引用
- Benson RA, Meecham LA, Hewitt CA, et al. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial. Eur J Vasc Endovasc Surg. 2019. PMID: 31201136. doi:10.1016/j.ejvs.2019.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。